Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. (2-((3r,5r)-3,6-diamino-5-hydroxyhexanoyl)-1-methylhydrazino) Acetic Acid
2. Negamycin, (threo-d)-isomer
1. 33404-78-3
2. B15l87q2hq
3. L-threo-hexonic Acid, 3,6-diamino-2,3,4,6-tetradeoxy-, 2-(carboxymethyl)-2-methylhydrazide
4. Unii-b15l87q2hq
5. Neg
6. Brn 4687658
7. Negamycin [mi]
8. (+)-negamycin
9. Negamycin, (+)-
10. Chembl78628
11. Schembl564074
12. Acetic Acid, (2-(3,6-diamino-5-hydroxyhexanoyl)-1-methylhydrazino)-
13. Dtxsid701043349
14. 3,6-diamino-2,3,4,6-tetradeoxy-l-threo-hexonic Acid 2-(carboxymethyl)-2-methylhydrazide
15. Q27274241
16. 2-[[[(3r,5r)-3,6-diamino-5-hydroxyhexanoyl]amino]-methylamino]acetic Acid
17. (2-((3r,5r)-3,6-diamino-5-hydroxyhexanoyl)-1-methylhydrazino) Acetic Acid
18. {2-[(3r,5r)-3,6-diamino-5-hydroxyhexanoyl]-1-methylhydrazino}acetic Acid (non-preferred Name)
19. 3,6-diamino-1-[2-(carboxymethyl)-2-methylhydrazino]-2,3,4,6-tetradeoxy-l-threo-hexose
| Molecular Weight | 248.28 g/mol |
|---|---|
| Molecular Formula | C9H20N4O4 |
| XLogP3 | -5.1 |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 8 |
| Exact Mass | 248.14845513 g/mol |
| Monoisotopic Mass | 248.14845513 g/mol |
| Topological Polar Surface Area | 142 Ų |
| Heavy Atom Count | 17 |
| Formal Charge | 0 |
| Complexity | 261 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
17
PharmaCompass offers a list of Negamycin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Negamycin manufacturer or Negamycin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Negamycin manufacturer or Negamycin supplier.
PharmaCompass also assists you with knowing the Negamycin API Price utilized in the formulation of products. Negamycin API Price is not always fixed or binding as the Negamycin Price is obtained through a variety of data sources. The Negamycin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Negamycin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Negamycin, including repackagers and relabelers. The FDA regulates Negamycin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Negamycin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Negamycin supplier is an individual or a company that provides Negamycin active pharmaceutical ingredient (API) or Negamycin finished formulations upon request. The Negamycin suppliers may include Negamycin API manufacturers, exporters, distributors and traders.
Negamycin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Negamycin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Negamycin GMP manufacturer or Negamycin GMP API supplier for your needs.
A Negamycin CoA (Certificate of Analysis) is a formal document that attests to Negamycin's compliance with Negamycin specifications and serves as a tool for batch-level quality control.
Negamycin CoA mostly includes findings from lab analyses of a specific batch. For each Negamycin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Negamycin may be tested according to a variety of international standards, such as European Pharmacopoeia (Negamycin EP), Negamycin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Negamycin USP).
